DEC 31, 2020 6:00 AM PST

Arthritis Medication Resolves Previously Untreatable Skin Condition

WRITTEN BY: Tara Fernandez

Bumpy, inflamed, ring-shaped lesions on the skin—granuloma annulare (GA) is a chronic, inflammatory skin condition with no treatment options. For patients with particularly severe forms of the disease, this can take a toll on their quality of life. Unfortunately, until now, the triggers of this skin condition and ways to treat it have remained a mystery.

Researchers from Yale have recently made a breakthrough in the field in a study that outlines the underlying causes of the disease and a potential therapeutic strategy for alleviating its symptoms.

“The condition hasn’t been thoroughly investigated using newer approaches until now because it’s often considered mostly a cosmetic issue,” said dermatology expert William Damsky who led the study, which was published in the Journal of Allergy and Clinical Immunology.

Damsky and colleagues studied GA patients with lesions that covered around half their bodies. They isolated individual skin cells from these lesions and used single-cell RNA sequencing methods to map their genetic profiles. The scientists observed that the cytokines interferon gamma and oncostatin M were involved in setting off inflammatory cascades in skin cells called fibroblasts. These cells form the connective tissue in skin and tendons, giving skin its strength by secreting a protein called collagen. In GA, fibroblasts were found to be in an altered, chronically activated state due to the elevated inflammation.

“We now better understand the signals [the aforementioned cytokines] that lead to the disorder and can choose medications more likely to be effective,” Damsky said.

By leveraging the new role these cytokines play in sparking inflammation, the team tested an anti-inflammatory treatment called tofacitinib. The drug, approved for rheumatoid arthritis treatment, was found to clear up GA lesions in patients who had struggled with the condition for years. Three of the patients saw a complete resolution of the disease after treatment.

“The improvement has been life-changing,” commented Damsky. “Patients can now feel good about wearing shorts and short-sleeved shirts in public, things most of us take for granted.” Trials to test the potential of the drug in larger cohorts of GA patients are in the works.

“We showed that there is a very viable treatment approach for patients with this disorder,” added Damsky.

 

 

Sources: Yale News, Journal of Allergy, and Clinical Immunology.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JUL 20, 2021
Immunology
Coronavirus Variants No Match Against Newly-Discovered Antibody
JUL 20, 2021
Coronavirus Variants No Match Against Newly-Discovered Antibody
Over 940 million people around the world have been fully vaccinated. But, as the World Health Organization warns, t ...
JUL 22, 2021
Immunology
"Stunning" Anti-Inflammatory Effects of a Fermented Food Diet
JUL 22, 2021
"Stunning" Anti-Inflammatory Effects of a Fermented Food Diet
Researchers at Stanford University have found that consuming fermented foods such as yogurt, sauerkraut, and kombucha te ...
SEP 16, 2021
Immunology
Trapped! An Immune Cell Tag Team Takes Down Bacteria.
SEP 16, 2021
Trapped! An Immune Cell Tag Team Takes Down Bacteria.
Spiders are among nature’s most sophisticated hunters. Many build intricate webs out of silk and lie in wait for a ...
SEP 26, 2021
Coronavirus
LIBRA-Seq ID's a Potent Antibody to Fight COVID-19
SEP 26, 2021
LIBRA-Seq ID's a Potent Antibody to Fight COVID-19
Humans can produce millions or even billions of antibodies, so only so many can be captured and screened. But those anti ...
OCT 05, 2021
Immunology
Inflammation Overload Triggers 'Microclots' in COVID Long-Haulers
OCT 05, 2021
Inflammation Overload Triggers 'Microclots' in COVID Long-Haulers
Months after COVID symptoms have subsided, some individuals continue to grapple with the lingering effects of the infect ...
OCT 19, 2021
Cell & Molecular Biology
Mouse Fathers Passed Immunity Onto Offpsring After Infection
OCT 19, 2021
Mouse Fathers Passed Immunity Onto Offpsring After Infection
Parents pass their genes on to their children. But they can pass down other things too with epigenetic marks, chemical t ...
Loading Comments...